|drug4138||telephone consult Wiki||1.00|
|drug4048||pre-operative screening Wiki||1.00|
There is one clinical trial.
The Positive Affect Regulation sKills (PARK) Course is an online program containing a series of positive emotion skills for individuals experiencing stress and distress as a result of the COVID-19 outbreak, recommended/mandatory social distancing, and other related stressors (e.g., loss of income, shortages of daily essentials, etc.). The study specifically targets positive emotion, and offers an array of skills in a self-guided online delivery platform, making the program accessible and convenient in times when social distancing and self-quarantine are paramount to quell the spread of COVID-19. Our main aims are: Aim 1: To explore the effects of PARK on anxiety, depression, feelings of social isolation, positive affect, and a sense of meaning and purpose. Aim 2: To test whether age or gender moderate the effects of the program.
Description: Assessed using PROMIS Anxiety (CAT)Measure: Change in anxiety Time: Baseline, 6 weeks, 6 months
Description: Assessed using PROMIS Depression (CAT)Measure: Change in depression Time: Baseline, 6 weeks, 6 months
Description: Assessed using PROMIS Social Isolation (CAT)Measure: Change in feelings of social isolation Time: Baseline, 6 weeks, 6 months
Description: Assessed using PROMIS Positive Affect (CAT)Measure: Change in positive affect Time: Baseline, 6 weeks, 6 months
Description: Assessed using PROMIS Meaning and Purpose (CAT)Measure: Change in sense of meaning and purpose Time: Baseline, 6 weeks, 6 months
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports